Diacylglycerol kinase ? couples farnesoid X receptor-dependent bile acid signalling to Akt activation and glucose homoeostasis in hepatocytes.
Ontology highlight
ABSTRACT: DGKs (diacylglycerol kinases) catalyse the conversion of diacylglycerol into PA (phosphatidic acid), a positive modulator of mTOR (mammalian target of rapamycin). We have found that chenodeoxycholic acid and the synthetic FXR (farnesoid X receptor) ligand GW4064 induce the mRNA and protein expression of DGK? in the HepG2 cell line and in primary human hepatocytes. Reporter gene studies using 1.5 kB of the DGK? promoter fused to the luciferase gene revealed that bile acids increase DGK? transcriptional activity. Mutation of putative FXR-binding sites attenuated the ability of GW4046 to increase DGK? luciferase activity. Consistent with this finding, ChIP (chromatin immunoprecipitation) assays demonstrated that bile acid signalling increased the recruitment of FXR to the DGK? promoter. Furthermore, GW4064 evoked a time-dependent increase in the cellular concentration of PA. We also found that GW4064 and PA promote the phosphorylation of mTOR, Akt and FoxO1 (forkhead box O1), and that silencing DGK? expression significantly abrogated the ability of GW4046 to promote the phosphorylation of these PA-regulated targets. DGK? was also required for bile-acid-dependent decreased glucose production. Taken together, our results establish DGK? as a key mediator of bile-acid-stimulated modulation of mTORC2 (mTOR complex 2), the Akt pathway and glucose homoeostasis.
SUBMITTER: Cai K
PROVIDER: S-EPMC3976421 | biostudies-literature | 2013 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA